Valeo Pharma Inc. provided revenue guidance for the fourth quarter of 2022. The company expects revenues in the fourth quarter to exceed $11 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.095 CAD | +5.56% | -.--% | -47.22% |
25/04 | Transcript : Valeo Pharma Inc. - Shareholder/Analyst Call | |
22/03 | Valeo Pharma Inc. Announces Appointment of Al Moghaddam to Board of Directors | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.22% | 68.71L | |
+40.73% | 74TCr | |
+32.83% | 60TCr | |
-6.30% | 35TCr | |
+15.15% | 32TCr | |
+4.05% | 28TCr | |
+15.00% | 24TCr | |
+9.78% | 21TCr | |
-5.52% | 21TCr | |
+6.17% | 16TCr |
- Stock Market
- Equities
- VPH Stock
- News Valeo Pharma Inc.
- Valeo Pharma Inc. Provides Revenue Guidance for the Fourth Quarter of 2022